WHO to test three existing drugs for use with COVID

The World Health Organization said it will soon begin testing three drugs currently used for other diseases to see if they might help patients suffering from the coronavirus.

Tedros Adhanom Ghebreyesus, WHO Director-General said "Today, we are pleased to announce the next phase in the solidarity trial called Solidarity Plus Solidarity Plus will test three drugs: artesunate, a treatment for severe malaria; imatinib, a drug for certain cancers; and infliximab, a treatment for immune system disorders such as Crohn's disease. These drugs were chosen by an independent panel of experts that evaluates all the available evidence on all potential therapeutics. The trial involves thousands of researchers at more than 600 hospitals in 52 countries."

 WHO's ongoing study into COVID-19 treatments previously assessed four drugs.  Among its findings, the agency determined that remdesivir and hydroxychloroquine didn't help people hospitalized with the virus.